INVIVO THERAPEUTICS HOLDINGS CORP. Annual Return On Equity in % from 2012 to 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Invivo Therapeutics Holdings Corp. quarterly/annual Return On Equity history and growth rate from 2012 to 2022.
  • Invivo Therapeutics Holdings Corp. Return On Equity for the quarter ending September 30, 2023 was -75 %, a 3.93% increase year-over-year.
  • Invivo Therapeutics Holdings Corp. annual Return On Equity for 2022 was -77.5 %, a 72% decline from 2021.
  • Invivo Therapeutics Holdings Corp. annual Return On Equity for 2021 was -45 %, a 42.2% increase from 2020.
  • Invivo Therapeutics Holdings Corp. annual Return On Equity for 2020 was -77.9 %, a 38.3% increase from 2019.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 -77.5 -32.4 -72% Jan 1, 2022 Dec 31, 2022
2021 -45 +32.9 +42.2% Jan 1, 2021 Dec 31, 2021
2020 -77.9 +48.4 +38.3% Jan 1, 2020 Dec 31, 2020
2019 -126 +102 +44.7% Jan 1, 2019 Dec 31, 2019
2018 -228 -69.5 -43.7% Jan 1, 2018 Dec 31, 2018
2017 -159 -92.4 -139% Jan 1, 2017 Dec 31, 2017
2016 -66.5 +157 +70.3% Jan 1, 2016 Dec 31, 2016
2015 -224 -51.2 -29.7% Jan 1, 2015 Dec 31, 2015
2014 -172 +230 +57.2% Jan 1, 2014 Dec 31, 2014
2013 -403 -216 -116% Jan 1, 2013 Dec 31, 2013
2012 -186 Jan 1, 2012 Dec 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.